SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Cash Flow from Operating Activities | ₹-360 Cr | ₹-429 Cr | ₹-69 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-360 Cr |
| Mar2024 | ₹-429 Cr |
| Mar2023 | ₹-69 Cr |
How is Cash Flow from Operating Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-360 Cr | Negative | |
| Mar2024 | ₹-429 Cr | Negative | |
| Mar2023 | ₹-69 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,403.5 Cr | 1.5% | -10.6% | -32.6% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹26,517.4 Cr | 0.6% | 3.5% | -24.3% | Stock Analytics | |
| SAGILITY INDIA | ₹24,797.0 Cr | 1.4% | 6.1% | 3.2% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹9,498.9 Cr | -0.4% | 0.2% | -7.1% | Stock Analytics | |
| JUST DIAL | ₹6,243.6 Cr | 1.4% | 1.2% | -27% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹3,531.5 Cr | 1.9% | -3.5% | -31.2% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 1.5% |
-10.6% |
-32.6% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses